These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26223463)

  • 1. HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process.
    Douša M; Klvaňa R; Doubský J; Srbek J; Richter J; Exner M; Gibala P
    J Chromatogr Sci; 2016 Feb; 54(2):119-24. PubMed ID: 26223463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process.
    Liu DQ; Chen TK; McGuire MA; Kord AS
    J Pharm Biomed Anal; 2009 Sep; 50(2):144-50. PubMed ID: 19427156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.
    Venugopal N; Bhaskar Reddy AV; Gangadhar Reddy K; Madhavi V; Madhavi G
    J Pharm Biomed Anal; 2012 Nov; 70():592-7. PubMed ID: 22749172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile.
    Wolff FC; Dillenburg TL; Venzon Antunes M; Linden R; Comparsi Wagner S; Verza SG
    Biomed Chromatogr; 2018 Jul; 32(7):e4222. PubMed ID: 29488235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance.
    Vijaya Bhaskar Reddy A; Venugopal N; Madhavi G; Gangadhara Reddy K; Madhavi V
    J Pharm Biomed Anal; 2013 Oct; 84():84-9. PubMed ID: 23816589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin.
    Douša M; Jireš J
    J Pharm Biomed Anal; 2020 Nov; 191():113573. PubMed ID: 32896809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of a de-fluorinated analogue of casopitant mesylate by normal-phase liquid chromatography/mass spectrometry.
    Dams R; Bernabe E; Nicoletti A; Loda C; Martini L; Papini D
    Rapid Commun Mass Spectrom; 2010 Sep; 24(17):2650-4. PubMed ID: 20740542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a HILIC-MS method for the determination of amino acid and non-amino acid impurities in histidine.
    Xu Q; Tadjimukhamedov FK
    J Pharm Biomed Anal; 2022 Sep; 219():114936. PubMed ID: 35853262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in trace analysis of pharmaceutical genotoxic impurities.
    Liu DQ; Sun M; Kord AS
    J Pharm Biomed Anal; 2010 Apr; 51(5):999-1014. PubMed ID: 20022442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
    Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of vortioxetine and its degradation product in bulk and tablets, by LC-DAD and MS/MS methods.
    de Diego M; Correa D; Mennickent S; Godoy R; Vergara C
    Biomed Chromatogr; 2018 Nov; 32(11):e4340. PubMed ID: 30001570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a sensitive method for alkyl sulfonate genotoxic impurities determination in drug substances using gas chromatography coupled to triple quadrupole mass spectrometry.
    Liu Z; Fan H; Zhou Y; Qian X; Tu J; Chen B; Duan G
    J Pharm Biomed Anal; 2019 May; 168():23-29. PubMed ID: 30784886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of potential genotoxic impurity 3-aminopyridine in linagliptin active pharmaceutical ingredient using HILIC-UV.
    Al-Sabti B; Harbali J
    Biomed Chromatogr; 2020 Nov; 34(11):e4930. PubMed ID: 32579716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability-indicating reversed-phase HPLC method development and characterization of impurities in vortioxetine utilizing LC-MS, IR and NMR.
    Liu L; Cao N; Ma X; Xiong K; Sun L; Zou Q; Yao L
    J Pharm Biomed Anal; 2016 Jan; 117():325-32. PubMed ID: 26412721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple, sensitive, and straightforward LC-MS approach for rapid analysis of three potential genotoxic impurities in rabeprazole formulations.
    Yenugu VMR; Ambavaram VBR; Moniruzzaman M; Madhavi G
    J Sep Sci; 2018 Nov; 41(21):3966-3973. PubMed ID: 30138541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
    Liu DQ; Sun M; Wu L
    Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.